Coronary Responses and Differential Mechanisms of Late Stent Thrombosis Attributed to First-Generation Sirolimus- and Paclitaxel-Eluting Stents

被引:258
作者
Nakazawa, Gaku [1 ]
Finn, Aloke V. [2 ]
Vorpahl, Marc [1 ]
Ladich, Elena R. [1 ]
Kolodgie, Frank D. [1 ]
Virmani, Renu [1 ]
机构
[1] CVPath Inst, Gaithersburg, MD 20878 USA
[2] Emory Univ, Sch Med, Atlanta, GA USA
关键词
drug-eluting stent; malapposition; pathology; stent thrombosis; vascular response; INTRAVASCULAR ULTRASOUND; BARE-METAL; DEGRADATION-PRODUCTS; FOLLOW-UP; IMPLANTATION; APPOSITION; ASSOCIATION; RESTENOSIS; INSIGHTS; TRIALS;
D O I
10.1016/j.jacc.2010.05.066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The purpose of this study was to assess the mechanism(s) of late stent thrombosis (LST) and vascular healing responses in first-generation polymeric drug-eluting stents (DES). Background Recent clinical trials have reported variations in late lumen loss between first-generation sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES). Little is known, however, about the vascular responses, time course of healing, and underlying mechanism(s) of complications of LST between platforms in human coronary implants. Methods The overall analysis included 174 cases (230 DES lesions) from the CVPath Institute's stent registry. Histomorphometry was performed on coronary stents from 127 patients (171 lesions) who died >= 30 days after receiving stent implants in which fibrin deposition, endothelial strut coverage, inflammatory response, and mechanism(s) of in-stent thrombosis were assessed. Results Both platforms demonstrated increased neointimal thickness over time where values were greater in PES (mean 0.13 mm; range 0.03 to 0.20 mm) than SES (mean 0.10 mm; range 0.04 to 0.15 mm; p = 0.04). The percentage of uncovered struts was similar between SES and PES including stents with LST (SES = 21% vs. PES = 27%; p = 0.47). The underlying mechanism(s) of LST, however, was strikingly different between platforms; localized strut hypersensitivity was exclusive to SES, whereas malapposition secondary to excessive fibrin deposition was the underlying cause in PES. Moreover, although both PES and SES showed nearly complete strut coverage after 12 months for on-label use, the majority of stents placed for off-label indications remained unhealed after 12 months in both types of DES. Conclusions Differential mechanisms of LST involving either hypersensitivity or excessive fibrin were identified between first-generation DES in which overall stent healing was further delayed in DES placed for off-label indications. (J Am Coll Cardiol 2011; 57: 390-8) (C) 2011 by the American College of Cardiology Foundation
引用
收藏
页码:390 / 398
页数:9
相关论文
共 34 条
[1]   Late incomplete stent apposition after sirolimus-eluting stent implantation - A serial intravascular ultrasound analysis [J].
Ako, J ;
Morino, Y ;
Honda, Y ;
Hassan, A ;
Sonoda, S ;
Yock, PG ;
Leon, MB ;
Moses, JW ;
Bonneau, HN ;
Fitzgerald, PJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (06) :1002-1005
[2]  
[Anonymous], 2007, Robbins Basic Pathology
[3]   Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation - Insights from serial intravascular ultrasound analysis in the TAXUS II study [J].
Aoki, J ;
Colombo, A ;
Dudek, D ;
Banning, AP ;
Drzewiecki, J ;
Zmudka, K ;
Schiele, F ;
Russell, ME ;
Koglin, J ;
Serruys, PW .
CIRCULATION, 2005, 112 (25) :3876-3883
[4]   Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients [J].
Aoki, J ;
Abizaid, AC ;
Serruys, PW ;
Ong, ATL ;
Boersma, E ;
Sousa, JE ;
Bruining, N .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (09) :1670-1676
[5]   Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation [J].
Cook, Stephane ;
Wenaweser, Peter ;
Togni, Mario ;
Billinger, Michael ;
Morger, Cyrill ;
Seiler, Christian ;
Vogel, Rolf ;
Hess, Otto ;
Meier, Bernhard ;
Windecker, Stephan .
CIRCULATION, 2007, 115 (18) :2426-2434
[6]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[7]   Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study [J].
Daemen, Joost ;
Wenaweser, Peter ;
Tsuchida, Keiichi ;
Abrecht, Linda ;
Sophia, Vaina ;
Morger, Cyrill ;
Kukreja, Neville ;
Jueni, Peter ;
Sianos, Georgios ;
Hellige, Gerrit ;
van Domburg, Ron T. ;
Hess, Otto M. ;
Boersma, Eric ;
Meier, Bernhard ;
Windecker, Stephan ;
Serruys, Patrick W. .
LANCET, 2007, 369 (9562) :667-678
[8]   Pathological analysis of local delivery of paclitaxel via a polymer-coated stent [J].
Farb, A ;
Heller, PF ;
Shroff, S ;
Cheng, L ;
Kolodgie, FD ;
Carter, AJ ;
Scott, DS ;
Froehlich, J ;
Virmani, R .
CIRCULATION, 2001, 104 (04) :473-479
[9]   Extracellular matrix changes in stented human coronary arteries [J].
Farb, A ;
Kolodgie, FD ;
Hwang, JY ;
Burke, AP ;
Tefera, K ;
Weber, DK ;
Wight, TN ;
Virmani, R .
CIRCULATION, 2004, 110 (08) :940-947
[10]   Morphological predictors of restenosis after coronary stenting in humans [J].
Farb, A ;
Weber, DK ;
Kolodgie, FD ;
Burke, AP ;
Virmani, R .
CIRCULATION, 2002, 105 (25) :2974-2980